Keywords: millennium, bows, out, anormed, bidding, massachusetts, usa-headquartered
Millennium bows out of AnorMED bidding
Article | 23 October 2006
Massachusetts, USA-headquartered Millennium Pharmaceuticals says it will not raise its takeover offer of $12 per share, or a total of $515.0 million, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
